Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Touchstone Innovations, formerly known as Imperial Innovations, was a prominent UK-based technology commercialization and investment company. It specialized in identifying and developing intellectual property originating from world-leading universities, particularly Imperial College London. The company's primary focus areas included life sciences, healthcare, and physical sciences, where it provided seed funding and strategic guidance to spin-out companies. Touchstone played a critical role in the UK's "Golden Triangle" ecosystem, bridging the gap between academic research and commercial success. In 2017, the company was acquired by IP Group in a deal that consolidated two of the UK's largest intellectual property investors. Following the acquisition, its operations and portfolio were integrated into IP Group's broader platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Touchstone Innovations.